MoonLake Immunotherapeutics achieves landmark milestone with positive Phase 2 results for Nanobody® sonelokimab in hidradenitis suppurativa
Globe Newswire25-06-2023, 20:00
FloQast Partners with CFGI to Drive Financial Transformation and Accounting Excellence in APAC 3-10-2024, 07:00